Recombinant shingles vaccine
Recombinant shingles vaccine has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Mar 4, 2026: “Infection, vaccination and risk of dementia: a proposed immunological model”.
1 paper studies it1 findingUpdated
See all 1 papers on recombinant shingles vaccine
What is recombinant shingles vaccine linked with?
1Studies link recombinant shingles vaccine with dementia.
Dementia
downin humans1
1 study
Dementia
downin humans1
Recombinant shingles vaccine lowers the risk of dementia in humans.
“Over the last few years, the AS01-adjuvanted recombinant shingles vaccine has also been associated with reduced risk in several studies.”
Review
Infection, vaccination and risk of dementia: a proposed immunological model
Frontiers in immunology
Latest
1 paper in 12 monthsFrontiers in Immunology
Infection, vaccination and risk of dementia: a proposed immunological model
ReviewMechanisms